返回 
加入收藏
基于CiteSpace的沙库巴曲缬沙坦应用可视化分析
x
请在关注微信后，向客服人员索取文件
| 篇名： | 基于CiteSpace的沙库巴曲缬沙坦应用可视化分析 |
| TITLE： | Visual analysis of the use of sacubitril/valsartan based on CiteSpace |
| 摘要： | 目的 分析沙库巴曲缬沙坦应用的研究现状及发展趋势。方法检索中国知网和WebofScience核心合集数据库中沙库巴曲缬沙坦应用的相关文献，运用CiteSpace5.8.R3软件对发文作者、国家/地区、发文机构、关键词进行分析。结果与结论共纳入中文文献1193篇、英文文献1060篇；年发文量呈递增趋势；美国（429篇）、英国（185篇）、中国（184篇）的发文量较多。中文、英文文献发文量最多的作者分别是张静（5篇）和SolomonSD（118篇）；中文文献作者间的合作交流较少，英文文献作者间的联系较为密切。中文、英文文献发文量最多的机构分别是郑州大学第一附属医院心内科（9篇）、徐州医科大学附属医院心内科（9篇）和瑞士诺华制药（134篇）；中文文献发文机构的总体发文量偏少且合作交流有限，英文文献发文机构联系密切。沙库巴曲缬沙坦治疗心力衰竭、高血压及相关合并症的临床疗效研究是中英文文献的研究热点。我国学者和研究团队未来需要加强合作交流，可就沙库巴曲缬沙坦治疗心力衰竭、高血压及相关合并症，改善氧化应激水平，与达格列净联合治疗效果评价等方面开展研究。 |
| ABSTRACT： | OBJECTIVE To analyze the research status and development trends of the use of sacubitril/valsartan. METHODS Related literature about the use of sacubitril/valsartan were retrieved from CNKI and the core database of Web of Science. CiteSpace 5.8.R3 software was used to analyze authors， countries/areas， institutions and keywords. RESULTS & CONCLUSIONS Totally 1 193 Chinese literature and 1 060 English literature were included. The number of literature increased， with numerous literature covering the United States （429）， the United Kingdom （185） and China （184）. ZHANG Jing （5） and Solomon S D （118） published the highest number of Chinese and English articles. The authors of Chinese literature had less cooperation while the authors of English literature were in close contact. Dept. of Cardiology in the First Affiliated Hospital of Zhengzhou University （9）， Dept. of Cardiology in the Affiliated Hospital of Xuzhou Medical University （9） and Novartis AG （134） had the highest quantity of publications of Chinese and English literature. The institutions of Chinese literature had a small number of overall publications and less cooperation while the institutions of English literature were closely connected. The clinical efficacy of sacubitril/valsartan for heart failure， hypertension and their complications were research hotspots in Chinese and English literature. Chinese scholars and research teams need to strengthen cooperation and communication in the future， as well as conduct research from the perspectives of sacubitril/valsartan in the treatment of heart failure， hypertension and related complication， the improvement of oxidative stress， and the evaluation of the efficacy of combination therapy with dapagliflozin. |
| 期刊： | 2023年第34卷第16期 |
| 作者： | 曹馨瑞；严思敏；张若彬；葛卫红 |
| AUTHORS： | CAO Xinrui，YAN Simin，ZHANG Ruobin，GE Weihong |
| 关键字： | 沙库巴曲缬沙坦；CiteSpace；可视化分析；热点 |
| KEYWORDS： | sacubitril/valsartan； CiteSpace； visual analysis； hotspot |
| 阅读数： | 60 次 |
| 本月下载数： | 9 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
